SMAD3 and dopa-responsive dystonia due to sepiapterin reductase deficiency: In addition, the main features that distinguish SMAD3‐related disorders (SRD) from MFS and other TGFβvs are precocious osteoarthritis (<50 years old) and Charcot–Marie–Tooth‐like neuropathy (Aubart et al., 2014).